The 25th World Congress of Dermatology took place in Singapore from 3-8 July at the Suntec Singapore Convention & Exhibition Centre.
Taking place once every four years and bringing together the world’s leading dermatologists, scientists and researchers, the event is a calendar hotspot for brands and experts presenting the latest in skin research.
Cosmetics Business has rounded-up key findings presented by the world’s biggest beauty players last week.
1. Pigmentary disorders affect half of women globally
These include vitiligo, post-inflammatory hyperpigmentation and melasma.
In the largest study of its kind, La Roche-Posay surveyed 48,000 people across 34 countries.
Nearly a third (28%) reported a strong impact on quality of life as a result of their PD and 44% of those with a PD reported hiding the visible part of their affected skin.
At the congress, L’Oréal presented Mexoryl 400, the patented ingredient in UVMune 400 by La Roche-Posay.
It is said to be L’Oréal’s first technology to protect skin against ultra-long UVA and prevent skin damage caused by photoageing, photo pollution, as well as the modification of genes that can lead to skin cancer.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.